Ropivacaine Versus Bupivacaine in Pediatric Tonsillectomy: A Systematic Review and Meta‐Analysis
OTO Open · 2025-07 · 9 (3)
DOI: 10.1002/oto2.70166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift OTO Open, online erschienen am 19.09.2025. Verfasst von Ebraheem Albazee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology-Head and Neck Surgery Kuwait Institute for Medical Specializations (KIMS) Kuwait City Kuwait. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To evaluate the analgesic efficacy and safety of local anesthetic infiltration in the tonsillar fossa using ropivacaine compared to bupivacaine in pediatric patients undergoing tonsillectomy. Data Sources CENTRAL, PubMed, Web of Science, Scopus, and Google Scholar. Review Methods Eligible randomized controlled trials (RCTs) were evaluated for risk of bias using Cochrane's Risk of Bias Tool (RoB‐2). The primary outcome was postoperative pain within the first 24 hours following tonsillectomy. Secondary outcomes included the time to first analgesic requirement and complication rates (ie, bleeding, airway obstruction, local anesthetic toxicity, and nausea). Data were synthesized using the standardized mean difference (SMD) for continuous outcomes and risk ratio (RR) for dichotomous outcomes, both reported with 95% confidence intervals (CI).
Results
Seven RCTs with a total of 375 patients were analyzed. Regarding posttonsillectomy pain scores, there was no significant difference between ropivacaine and bupivacaine at 1 hour (SMD = −0.01, 95% confidence interval [CI] [−0.36, 0.34]), 2 hours (SMD = 0.03, 95% CI [−0.45, 0.51]), 4 hours (SMD = −0.17, 95% CI [−0.39, 0.06]), 6‐8 hours (SMD = 0.04, 95% CI [−0.38, 0.46]), and 12 hours (SMD = −0.23, 95% CI [−0.62, 0.15]). However, at 24 hours, ropivacaine demonstrated a superior effect compared to bupivacaine (SMD = −0.23, 95% CI [−0.43, −0.03]). There was no significant difference between ropivacaine and bupivacaine in terms of time to first analgesia and complication rates ( P > .05).
Conclusion
This meta‐analysis demonstrated that ropivacaine and bupivacaine offer comparable clinical analgesic efficacy and safety profiles in pediatric patients undergoing tonsillectomy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Otorhinolaryngology-Head and Neck Surgery Kuwait Institute for Medical Specializations (KIMS) Kuwait City Kuwait.
- Department of Otolaryngology-Head and Neck Surgery Al-Jahra Hospital Al-Jahra Kuwait.
- Department of Surgery, Faculty of Medicine University of Jordan Amman Jordan.
- Department of Internships Kuwait Institute for Medical Specializations (KIMS) Kuwait City Kuwait.
ORCID-Profile: Ebraheem Albazee, Khaled Alenezi, Abdulwahab Alkandari, Abdullah Al Sahli, Faisal Almulla, Khalaf A Alnowaishiri, Athari Alwael
Zitieren
APA
Albazee, E., Alenezi, K., Alkandari, A., Sahli, A. A., Almulla, F., Alnowaishiri, K. A., & Alwael, A. (2025). Ropivacaine Versus Bupivacaine in Pediatric Tonsillectomy: A Systematic Review and Meta‐Analysis. OTO Open, 9(3). https://doi.org/10.1002/oto2.70166
Vancouver
Albazee E, Alenezi K, Alkandari A, Sahli AA, Almulla F, Alnowaishiri KA, et al. Ropivacaine Versus Bupivacaine in Pediatric Tonsillectomy: A Systematic Review and Meta‐Analysis. OTO Open. 2025;9(3). doi:10.1002/oto2.70166
BibTeX
@article{Albazee2025,
author = {Albazee, Ebraheem and Alenezi, Khaled and Alkandari, Abdulwahab and Sahli, Abdullah Al and Almulla, Faisal and Alnowaishiri, Khalaf A and Alwael, Athari},
title = {Ropivacaine Versus Bupivacaine in Pediatric Tonsillectomy: A Systematic Review and Meta‐Analysis},
journal = {OTO Open},
year = {2025},
volume = {9},
number = {3},
doi = {10.1002/oto2.70166}
}
EUVIMED